Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GGT1 | P19440 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 4/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.34 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | GNPAT | O15228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7054962 | 1.00 | CA2 (0.41) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL31435019 | 1.00 | CA2 (0.41) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL3841887 | 1.00 | CA2 (0.41) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL39257 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL15637714 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL4992798 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL5825896 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL414800 | 0.93 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL23248621 | 0.92 | CA2 (0.37) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL8660403 | 0.92 | CA2 (0.37) | CA2CA4TDP1SMN1; SMN2GGT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250136488-A1 | Extended- and Multimodal-Release Compositions | Finoric LLC | 2025-05-01 | — | — | US | claimed |
| EP-1021394-B1 | PROCESS FOR THE PREPARATION OF FERRIC CHELATE SOLUTIONS OF ALKALI METAL POLYAMINO SUCCINIC ACIDS | DOW CHEMICAL CO (US) | 2003-04-23 | — | — | EP | claimed |
| EP-0850293-B1 | SUCCINIC ACID DERIVATIVE DEGRADABLE CHELANTS, USES AND COMPOSITIONS THEREOF | DOW CHEMICAL CO (US) | 2001-10-17 | — | — | EP | claimed |
| US-20250136488-A1 | Extended- and Multimodal-Release Compositions | Finoric LLC | 2025-05-01 | — | — | US | disclosed |
| EP-1455846-B1 | CELLULOSE FIBERS TREATED WITH ACIDIC ODOR CONTROL AGENTS | KIMBERLY CLARK CO (US) | 2009-04-15 | — | — | EP | disclosed |
| EP-1154806-B1 | LAYER MATERIALS TREATED WITH SURFACTANT-MODIFIED CHELATING AGENTS | KIMBERLY CLARK CO (US) | 2005-10-26 | — | — | EP | disclosed |
| US-6852904-B2 | Cellulose fibers treated with acidic odor control agents | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2005-02-08 | — | — | US | disclosed |
| US-6767553-B2 | CARBOXYLIC ACID-BASED ODOR CONTROL AGENT, ESPECIALLY CITRIC, MALIC OR TARTARIC ACID; AND AN ORGANOSILICONE POLYMER BINDER. | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-07-27 | — | — | US | disclosed |
| US-6652845-B2 | Long lasting prevention or reduction of ammonia smells | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-11-25 | — | — | US | disclosed |
| US-20030144637-A1 | Cellulose fibers treated with acidic odor control agents | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-31 | — | — | US | disclosed |
| US-20030124171-A1 | Natural fibers treated with acidic odor control/binder systems | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-03 | — | — | US | disclosed |
| US-20030113289-A1 | Layer materials treated with durable acidic odor control/binder systems | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030124171-A1 | Natural fibers treated with acidic odor control/binder systems | OR10J3, OR51E2, FABP2 | CA2 294/4885CA4 64/4885TDP1 4762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.